Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

Some Echo devices have a feature that allows you to block voice recordings from being sent to the cloud, but Amazon is ...

Edwards Lifesciences Corp. closed 27.91% below its 52-week high of $96.12, which the company achieved on March 28th.

RIT recognized faculty-researchers who have reached or surpassed $1 million in funding for innovative research projects ...